Search for new lung cancer biomarkers using 13C-labeled glucose

JRCT ID: jRCTs051200038

Registered date:30/07/2020

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Resectable primary lung cancer
• Date of first enrollment: 24/08/2020
• Target sample size: 6
• Study type: Interventional
• Intervention(s): Administration of 13C glucose

Outcome(s)

• Primary Outcome: Identification of derived metabolites in blood and urine after 13C glucose administration
• Secondary Outcome: Whether or not adverse events have occurred

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: < 80age old
• Gender: Both

Include criteria

(1) Patients who are at least 20 years old and under 80 years old at the time of obtaining consent
(2) PET-positive primary lung cancer patients who can be surgically resected
(3) Patients who have given their informed consent to participate in this clinical study

Exclude criteria

(1) Patients with other cancers
(2) Other patients judged inappropriate by the person in charge of this clinical study

Related Information

• Primary Sponsor: Yoshida Masaru